{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:09:44Z","timestamp":1787022584747,"version":"build-2736575974"},"reference-count":86,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Craniopharyngiomas are low-grade suprasellar intracranial tumours associated with hypothalamic\u2013pituitary axis dysfunction and obesity. This scoping review aimed to explore the potential impact of hyperphagic eating behaviour and appetitive factors on the development of craniopharyngioma-associated obesity and to identify areas for future intervention. PRISMA-ScR and JBI methodology was followed. Five databases and two trial registries were searched. All published studies of patients with childhood or adult-onset craniopharyngioma that addressed eating behaviours in conjunction with pharmaceutical\/surgical interventions, neuroimaging, endocrine responses, energy expenditure, sleep and\/or neuropsychology were included in this review. Evidence surrounding eating behaviours in craniopharyngioma patients was sparce with only 10 of the 50 included papers using validated eating behaviour assessments. Eating behaviour was included as a primary outcome (n=7), secondary outcome (n=12) or commented on without formal measurement (n=31). Few studies included patients with adult-onset craniopharyngioma (n=8) or compared patients with craniopharyngioma with and without obesity (n=2), and no papers were identified that attempted to modify eating behaviours as an intervention for craniopharyngioma-related obesity. Further understanding of eating behaviour in craniopharyngioma patients through longer-term research with validated measures will improve our understanding of mechanisms underlying craniopharyngioma-associated obesity and inform clinical practice by allowing treatments tailored for patient-centred care.<\/jats:p>","DOI":"10.1515\/jpem-2025-0589","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:11:17Z","timestamp":1771420277000},"page":"217-235","source":"Crossref","is-referenced-by-count":1,"title":["Impact of eating behaviour on craniopharyngioma-associated obesity"],"prefix":"10.1515","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5655-5289","authenticated-orcid":false,"given":"Danielle","family":"Eddy","sequence":"first","affiliation":[{"name":"Bristol Royal Hospital for Children, University Hospitals Bristol and Weston Foundation Trust , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8671-3145","authenticated-orcid":false,"given":"Rebecca L.","family":"Elsworth","sequence":"additional","affiliation":[{"name":"1980 NIHR Bristol Biomedical Research Centre, Diet and Physical Activity Theme, University of Bristol , Bristol , UK"},{"name":"1980 University of Bristol , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby Philip","family":"Candler","sequence":"additional","affiliation":[{"name":"Bristol Royal Hospital for Children, University Hospitals Bristol and Weston Foundation Trust , Bristol , UK"},{"name":"1980 NIHR Bristol Biomedical Research Centre, Diet and Physical Activity Theme, University of Bristol , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimra","family":"Naeem","sequence":"additional","affiliation":[{"name":"1980 University of Bristol , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Szymkowiak","sequence":"additional","affiliation":[{"name":"1980 University of Bristol , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-3016","authenticated-orcid":false,"given":"Rachel","family":"Perry","sequence":"additional","affiliation":[{"name":"1980 NIHR Bristol Biomedical Research Centre, Diet and Physical Activity Theme, University of Bristol , Bristol , UK"},{"name":"The National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-1330","authenticated-orcid":false,"given":"Blandine","family":"Gatta-Cherifi","sequence":"additional","affiliation":[{"name":"Endocrinology Department , CHU of Bordeaux , Bordeaux , France"},{"name":"Neurocentre Magendie, University of Bordeaux , Bordeaux , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-0410","authenticated-orcid":false,"given":"Elizabeth Clare","family":"Crowne","sequence":"additional","affiliation":[{"name":"Bristol Royal Hospital for Children, University Hospitals Bristol and Weston Foundation Trust , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2793-8552","authenticated-orcid":false,"given":"Elanor C.","family":"Hinton","sequence":"additional","affiliation":[{"name":"1980 NIHR Bristol Biomedical Research Centre, Diet and Physical Activity Theme, University of Bristol , Bristol , UK"},{"name":"1980 University of Bristol , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"2026030907573193812_j_jpem-2025-0589_ref_001","unstructured":"Gan, HE, Bulwer, C, Spoudeas, H. Pituitary and hypothalamic tumor syndromes in childhood. In: Feingold, KR, Anawalt, B, A, B, editors. South Dartmouth (MA): Endotext: NCBI Bookshelf; 2017."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_002","doi-asserted-by":"crossref","unstructured":"Muller, HL. Craniopharyngioma. Handb 2014;124:235\u201353. https:\/\/doi.org\/10.1016\/B978-0-444-59602-4.00016-2.","DOI":"10.1016\/B978-0-444-59602-4.00016-2"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_003","doi-asserted-by":"crossref","unstructured":"Bunin, GR, Surawicz, TS, Witman, PA, Preston-Martin, S, Davis, F, Bruner, JM, et al.. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;84:547\u201351. https:\/\/doi.org\/10.3171\/jns.1998.89.4.0547.","DOI":"10.3171\/jns.1998.89.4.0547"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_004","doi-asserted-by":"crossref","unstructured":"Dolecek, TA, Propp, JM, Stroup, NE, Kruchko, C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012;14:v1\u201349. https:\/\/doi.org\/10.1093\/neuonc\/nos218.","DOI":"10.1093\/neuonc\/nos218"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_005","doi-asserted-by":"crossref","unstructured":"Louis, DN, Ohgaki, H, Wiestler, OD, Cavenee, WK, Burger, PC, Jouvet, A, et al.. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97\u2013109. https:\/\/doi.org\/10.1007\/s00401-007-0278-6.","DOI":"10.1007\/s00401-007-0243-4"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_031","doi-asserted-by":"crossref","unstructured":"Karavitaki, N, Brufani, C, Warner, JT, Adams, CB, Richards, P, Ansorge, O, et al.. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 2005;62:397\u2013409. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02231.x.","DOI":"10.1111\/j.1365-2265.2005.02231.x"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_006","doi-asserted-by":"crossref","unstructured":"DeVile, CJ, Grant, DB, Hayward, RD, Stanhope, R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996;75:108\u201314. https:\/\/doi.org\/10.1136\/adc.75.2.108.","DOI":"10.1136\/adc.75.2.108"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_007","unstructured":"Amayiri, N, Swaidan, M, Kalaldeh, S, Barbar, M, Elayyan, M, Faqih, N, et al.. Morbidity associated with management of pediatric craniopharyngioma patients:ten years of experience in a developing country. Pediatr Blood Cancer 2013;3:138."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_008","doi-asserted-by":"crossref","unstructured":"Gautier, A, Godbout, A, Grosheny, C, Tejedor, I, Coudert, M, Courtillot, C, et al.. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab 2012;97:1258\u201367. https:\/\/doi.org\/10.1210\/jc.2011-2817.","DOI":"10.1210\/jc.2011-2817"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_009","doi-asserted-by":"crossref","unstructured":"Hidalgo, MG, Calvo, MTM, Blanco, LF, Castano, CV, Moreno, GAM, Argente, J, et al.. Endocrinological outcome in children and adolescents survivors of central nervous system tumours after a 5 year follow-up. Anales De Pediatria 2014;80:357\u201364. https:\/\/doi.org\/10.1016\/j.anpede.2013.06.002.","DOI":"10.1016\/j.anpede.2013.06.002"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_010","unstructured":"Children\u2019s Cancer and Leukaemia Group (CCLG). Craniopharyngioma: Guideline for the management of children and young people (CYP) aged <19 years UK: CCLG; 2021. Available from: https:\/\/www.cclg.org.uk\/guidelines"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_011","doi-asserted-by":"crossref","unstructured":"Garre, ML, Cama, A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 2007;19:471\u20139. https:\/\/doi.org\/10.1097\/mop.0b013e3282495a22.","DOI":"10.1097\/MOP.0b013e3282495a22"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_012","doi-asserted-by":"crossref","unstructured":"van Iersel, L, Brokke, KE, Adan, RAH, Bulthuis, LCM, van den Akker, ELT, van Santen, HM, et al.. Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocr Rev 2019;40:193\u2013235. https:\/\/doi.org\/10.1210\/er.2018-00017.","DOI":"10.1210\/er.2018-00017"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_013","doi-asserted-by":"crossref","unstructured":"Lee, M, Korner, J. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary 2009;12:87\u201395. https:\/\/doi.org\/10.1007\/s11102-008-0096-4.","DOI":"10.1007\/s11102-008-0096-4"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_014","doi-asserted-by":"crossref","unstructured":"Roth, CL. Hypothalamic obesity in craniopharyngioma patients: disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention. J clini med 2015;4:1774\u201397. https:\/\/doi.org\/10.3390\/jcm4091774.","DOI":"10.3390\/jcm4091774"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_015","doi-asserted-by":"crossref","unstructured":"Heinks, K, Boekhoff, S, Hoffmann, A, Warmuth-Metz, M, Eveslage, M, Peng, J, et al.. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine 2018;59:364\u201372. https:\/\/doi.org\/10.1007\/s12020-017-1489-9.","DOI":"10.1007\/s12020-017-1489-9"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_016","doi-asserted-by":"crossref","unstructured":"Muller, HL, Bruhnken, G, Emser, A, Faldum, A, Etavard-Gorris, N, Gebhardt, U, et al.. Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst 2005;21:975\u201380. https:\/\/doi.org\/10.1007\/s00381-004-1124-y.","DOI":"10.1007\/s00381-004-1124-y"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_017","doi-asserted-by":"crossref","unstructured":"Guran, T, Turan, S, Bereket, A, Akcay, T, Unluguzel, G, Bas, F, et al.. The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children. Eur J Pediatr 2009;168:1043\u20138. https:\/\/doi.org\/10.1007\/s00431-008-0876-x.","DOI":"10.1007\/s00431-008-0876-x"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_018","doi-asserted-by":"crossref","unstructured":"Roemmler-Zehrer, J, Geigenberger, V, Stormann, S, Losa, M, Crippa, V, Otto, B, et al.. Food intake regulating hormones in adult craniopharyngioma patients. Eur 2014;170:627\u201335. https:\/\/doi.org\/10.1530\/eje-13-0832.","DOI":"10.1530\/EJE-13-0832"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_019","doi-asserted-by":"crossref","unstructured":"Daubenbuchel, AMM, Hoffmann, A, Eveslage, M, Ozyurt, J, Lohle, K, Reichel, J, et al.. Oxytocin in survivors of childhood-onset craniopharyngioma. Endocrine 2016;54:524\u201331. https:\/\/doi.org\/10.1007\/s12020-016-1084-5.","DOI":"10.1007\/s12020-016-1084-5"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_020","doi-asserted-by":"crossref","unstructured":"Bomer, I, Saure, C, Caminiti, C, Ramos, JG, Zuccaro, G, Brea, M, et al.. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity. J Pediatr Endocrinol Metab 2015;28:1305\u201312. https:\/\/doi.org\/10.1515\/jpem-2015-0167.","DOI":"10.1515\/jpem-2015-0167"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_021","doi-asserted-by":"crossref","unstructured":"Holmer, H, Pozarek, G, Wirfalt, E, Popovic, V, Ekman, B, Bjork, J, et al.. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab 2010;95:5395\u2013402. https:\/\/doi.org\/10.1210\/jc.2010-0993.","DOI":"10.1210\/jc.2010-0993"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_022","doi-asserted-by":"crossref","unstructured":"Kim, RJ, Shah, R, Tershakovec, AM, Zemel, BS, Sutton, LN, Grimberg, A, et al.. Energy expenditure in obesity associated with craniopharyngioma. Childs Nerv Syst 2010;26:913\u20137. https:\/\/doi.org\/10.1007\/s00381-009-1078-1.","DOI":"10.1007\/s00381-009-1078-1"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_023","doi-asserted-by":"crossref","unstructured":"Harz, KJ, Muller, HL, Waldeck, E, Pudel, V, Roth, C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 2003;88:5227\u201331. https:\/\/doi.org\/10.1210\/jc.2002-021797.","DOI":"10.1210\/jc.2002-021797"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_024","doi-asserted-by":"crossref","unstructured":"Dodet, P, Noiray, C, Leu-Semenescu, S, Lefevre, E, Nigam, M, Faucher, P, et al.. Hypersomnia and narcolepsy in 42 adult patients with craniopharyngioma. Sleep 2023;46. https:\/\/doi.org\/10.1093\/sleep\/zsad032.","DOI":"10.1093\/sleep\/zsad032"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_087","doi-asserted-by":"crossref","unstructured":"McHill, AW, Wright, KPJr. Role of sleep and circadian disruption on energy expenditure and in metabolic predisposition to human obesity and metabolic disease. Obes Rev 2017;18:15\u201324.","DOI":"10.1111\/obr.12503"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_025","doi-asserted-by":"crossref","unstructured":"Elsworth, RL, Lithander, FE, Naeem, N, Elson, R, Narayan, K, Taylor-Miller, T, et al.. Exploring visual food-cue reactivity using functional neuroimaging in patients with childhood craniopharyngioma: a feasibility study. Appetite 2021;169. https:\/\/doi.org\/10.1016\/j.appet.2021.105564.","DOI":"10.1016\/j.appet.2021.105564"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_026","doi-asserted-by":"crossref","unstructured":"Roth, CL, Aylward, E, Liang, O, Kleinhans, NM, Pauley, G, Schur, EA, et al.. Functional neuroimaging in craniopharyngioma: a useful tool to better understand hypothalamic obesity? Obes Facts 2012;5:243\u201353. https:\/\/doi.org\/10.1159\/000338695.","DOI":"10.1159\/000338695"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_027","doi-asserted-by":"crossref","unstructured":"Ozyurt, J, Thiel, CM, Lorenzen, A, Gebhardt, U, Calaminus, G, Warmuth-Metz, M, et al.. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr 2014;164:876\u2013U261. https:\/\/doi.org\/10.1016\/j.jpeds.2013.12.010.","DOI":"10.1016\/j.jpeds.2013.12.010"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_028","doi-asserted-by":"crossref","unstructured":"Fjalldal, S, Follin, C, Svard, D, Rylander, L, Gabery, S, Petersen, A, et al.. Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma. Eur 2018;178:577\u201387. https:\/\/doi.org\/10.1530\/eje-18-0081.","DOI":"10.1530\/EJE-18-0081"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_029","doi-asserted-by":"crossref","unstructured":"Hinton, EC, Elsworth, RL, Naeem, N, Szymkowiak, SB, Perry, R, Candler, TP, et al.. Exploring eating behavior and psychological mechanisms associated with obesity in patients with craniopharyngioma: a scoping review protocol. JBI Evid Synth 2022;20:284\u201396. https:\/\/doi.org\/10.11124\/jbies-20-00514.","DOI":"10.11124\/JBIES-20-00514"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_030","doi-asserted-by":"crossref","unstructured":"Tricco, AC, Lillie, E, Zarin, W, O\u2019Brien, KK, Colquhoun, H, Levac, D, et al.. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/m18-0850.","DOI":"10.7326\/M18-0850"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_032","doi-asserted-by":"crossref","unstructured":"Peters, MD. In no uncertain terms: the importance of a defined objective in scoping reviews. JBI Database Syst Rev Implement Rep 2016;14:1\u20134. https:\/\/doi.org\/10.11124\/jbisrir-2016-2838.","DOI":"10.11124\/jbisrir-2016-2838"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_033","doi-asserted-by":"crossref","unstructured":"Bellhouse, J, Holland, A, Pickard, J. Psychiatric, cognitive and behavioural outcomes following craniopharyngioma and pituitary adenoma surgery. Br J Neurosurg 2003;17:319\u201326. https:\/\/doi.org\/10.1080\/02688690310001601207.","DOI":"10.1080\/02688690310001601207"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_042","doi-asserted-by":"crossref","unstructured":"Caminiti, C, Saure, C, Bomer, I, Brea, M, Gonzalez Ramos, J. Nutritional assessment of a population with a history of childhood craniopharyngioma seen at hospital \u201cprof. Dr. Juan P. Garrahan\u201d. Arch Argent Pediatr 2017;115:43\u20139. https:\/\/doi.org\/10.5546\/aap.2017.eng.43.","DOI":"10.5546\/aap.2017.eng.43"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_041","unstructured":"Coelho, I, Caetano, FB, Iraneta, A, Conceicao, C, Lopes, L, Galhardo, J, et al.. Hipothalamic syndrome in craniopharyngioma: pre and post-surgery. Hormone Res Paediatr 2023;96:545\u20136."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_034","doi-asserted-by":"crossref","unstructured":"Daubenbuchel, AM, Ozyurt, J, Boekhoff, S, Warmuth-Metz, M, Eveslage, M, Muller, HL, et al.. Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement. Pediatr Obes 2019;14. https:\/\/doi.org\/10.1111\/ijpo.12527.","DOI":"10.1111\/ijpo.12527"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_038","doi-asserted-by":"crossref","unstructured":"Dischinger, U, Kotzner, L, Kovatcheva-Datchary, P, Kleinschmidt, H, Haas, C, Perez, J, et al.. Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: a prospective, cross-sectional study. Metabolism 2023;138. https:\/\/doi.org\/10.1016\/j.metabol.2022.155341.","DOI":"10.1016\/j.metabol.2022.155341"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_035","doi-asserted-by":"crossref","unstructured":"Hinton, EC, Lithander, FE, Elsworth, RL, Hawton, K, Narayan, K, Szymkowiak, S, et al.. Evaluating eating behaviour, energy homeostasis and obesity in childhood onset craniopharyngioma: a feasibility study. Hormone Res Paediatr 2024;97:80\u201393. https:\/\/doi.org\/10.1159\/000530863.","DOI":"10.1159\/000530863"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_040","doi-asserted-by":"crossref","unstructured":"Hoffmann, A, Postma, FP, Sterkenburg, AS, Gebhardt, U, Muller, HL. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma. J Pediatr Endocrinol Metab 2015;28:35\u201343. https:\/\/doi.org\/10.1515\/jpem-2014-0415.","DOI":"10.1515\/jpem-2014-0415"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_037","doi-asserted-by":"crossref","unstructured":"Kayadjanian, N, Hsu, EA, Wood, AM, Carson, DS. Caregiver burden and its relationship to health-related quality of life in craniopharyngioma survivors. J Clin Endocrinol Metab 2024;109:E76\u201387. https:\/\/doi.org\/10.1210\/clinem\/dgad488.","DOI":"10.1210\/clinem\/dgad488"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_039","doi-asserted-by":"crossref","unstructured":"Postma, FP, Hoffmann, A, Gebhardt, U, Muller, HL. Eating behaviour and weight problems in long-term survivors of childhood craniopharyngioma\u00a0\u2013 results of the HIT endo trial. Endocrine Reviews Conference 96th Annu Meet Expo Endocr Soc ENDO 2014;35.","DOI":"10.1055\/s-0034-1372067"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_036","doi-asserted-by":"crossref","unstructured":"Roemmler-Zehrer, J, Geigenberger, V, Stormann, S, Ising, M, Pfister, H, Sievers, C, et al.. Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma. Clin Endocrinol 2015;82:106\u201314. https:\/\/doi.org\/10.1111\/cen.12523.","DOI":"10.1111\/cen.12523"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_047","unstructured":"Antoniou, MC, Diaz-Escagedo, P, Bouthors, T, Elowe-Gruau, E, Stoppa-Vaucher, S, Messerer, M, et al.. GLP-1 receptor agonist in a patient with craniopharyngioma-related obesity. Hormone Res Paediatr 2018;90:533."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_053","doi-asserted-by":"crossref","unstructured":"Arango, C, Rojas, MJ, Moreno, D, Parellada, M. Sibutramine for compulsive eating in hypothalamic deficiency. J Am Acad Child Adolesc Psychiatr 2002;41:1147\u20138. https:\/\/doi.org\/10.1097\/00004583-200210000-00004.","DOI":"10.1097\/00004583-200210000-00004"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_061","unstructured":"Balestrino, R, Losa, M, Barzaghi, L, Agosta, F, Filippi, M, Mortini, P. Treatment of neuro-psychological complications of craniopharyngioma with intranasal oxytocin: a case report. Neurol Sci 2022;43:S7\u20138."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_051","doi-asserted-by":"crossref","unstructured":"Castro-Dufourny, I, Carrasco, R, Pascual, JM. Hypothalamic obesity after craniopharyngioma surgery: treatment with a long acting glucagon like peptide 1 derivated. Endocrinol Diabetes Nutr 2017;64:182\u20134. https:\/\/doi.org\/10.1016\/j.endien.2017.04.002.","DOI":"10.1016\/j.endien.2017.04.002"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_052","unstructured":"Chatterjee, S, Hawton, K, Giri, D, Crowne, E. Are Glucagon-like peptide-1 (GLP-1) receptor agonists a new treatment option for hypothalamic obesity in the paediatric population: preliminary experience from a tertiary paediatric endocrine centre. Hormone Res Paediatr 2023;96:118."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_057","doi-asserted-by":"crossref","unstructured":"Elfers, CT, Roth, CL. Effects of methylphenidate on weight gain and food intake in hypothalamic obesity. Front Endocrinol 2011;2:78. https:\/\/doi.org\/10.3389\/fendo.2011.00078.","DOI":"10.3389\/fendo.2011.00078"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_043","doi-asserted-by":"crossref","unstructured":"Gatta-Cherifi, B, Mohammedi, K, Cariou, T, Poitou, C, Touraine, P, Raverot, G, et al.. Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial. Eur J Endocrinol 2024;190:257\u201365. https:\/\/doi.org\/10.1093\/ejendo\/lvae024.","DOI":"10.1093\/ejendo\/lvae024"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_058","doi-asserted-by":"crossref","unstructured":"Hsu, EA, Miller, JL, Perez, FA, Roth, CL. Oxytocin and naltrexone successfully treat hypothalamic obesity in a boy post-craniopharyngioma resection. J Clin Endocrinol Metab 2018;103:370\u20135. https:\/\/doi.org\/10.1210\/jc.2017-02080.","DOI":"10.1210\/jc.2017-02080"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_045","unstructured":"Lee, S. The effect of GLP-1 agonist in patients with hypothalamic obesity: prospective. Pilot Study Active Trial 2024. https:\/\/clinicaltrials.gov\/study\/NCT06217848."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_046","doi-asserted-by":"crossref","unstructured":"Lomenick, JP, Buchowski, MS, Shoemaker, AH. A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity. Obesity 2016;24:1222\u20135. https:\/\/doi.org\/10.1002\/oby.21493.","DOI":"10.1002\/oby.21493"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_054","doi-asserted-by":"crossref","unstructured":"Maniatis, AK, Simmons, JH, Zeitler, PS. Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance. Curr Opin Pediatr 2005;17:275\u20139. https:\/\/doi.org\/10.1097\/01.mop.0000156268.40887.0a.","DOI":"10.1097\/01.mop.0000156268.40887.0a"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_060","unstructured":"Mann, A, Fox, K, Kalitsi, J, Buchanan, CR, Arya, VB, Paloyelis, Y, et al.. Oxytocin improved neurobehavioural dysfunction in an adolescent post-craniopharyngioma surgery: a case report. Hormone Res Paediatr 2023;96:390\u20131."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_055","doi-asserted-by":"crossref","unstructured":"Mason, PW, Krawiecki, N, Meacham, LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 2002;156:887\u201392. https:\/\/doi.org\/10.1001\/archpedi.156.9.887.","DOI":"10.1001\/archpedi.156.9.887"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_059","doi-asserted-by":"crossref","unstructured":"McCormack, SE, Wang, Z, Wade, KL, Dedio, A, Cilenti, N, Crowley, J, et al.. A pilot randomized clinical trial of intranasal oxytocin to promote weight loss in individuals with hypothalamic obesity. J Endocr Soc 2023;7. https:\/\/doi.org\/10.1210\/jendso\/bvad037.","DOI":"10.1210\/jendso\/bvad037"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_063","doi-asserted-by":"crossref","unstructured":"Roth, C, Shoemaker, A, Gottschalk, M, Miller, J, Yuan, G, Chen, E, et al.. Efficacy and safety analysis of setmelanotide as a novel treatment for hypothalamic obesity. Obesity 2022;30:125.","DOI":"10.1530\/endoabs.90.P134"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_056","doi-asserted-by":"crossref","unstructured":"Sadatomo, T, Sakoda, K, Yamanaka, M, Kutsuna, M, Kurisu, K. Mazindol administration improved hyperphagia after surgery for craniopharyngioma\u00a0\u2013 case report. Neurol Med -Chir 2001;41:210\u20132. https:\/\/doi.org\/10.2176\/nmc.41.210.","DOI":"10.2176\/nmc.41.210"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_050","doi-asserted-by":"crossref","unstructured":"Sciacovelli, C, Moschione, G, Garelli, S, Pagotto, U. Semaglutide for treating obesity induced by craniopharyngioma resection: a successful case study. JCEM Case Rep 2023;1. https:\/\/doi.org\/10.1210\/jcemcr\/luad074.","DOI":"10.1210\/jcemcr\/luad074"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_044","doi-asserted-by":"crossref","unstructured":"Shoemaker, AH, Silver, HJ, Buchowski, M, Slaughter, JC, Yanovski, JA, Elfers, C, et al.. Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist. Int J Obes 2022;46:623\u20139. https:\/\/doi.org\/10.1038\/s41366-021-01043-6.","DOI":"10.1038\/s41366-021-01043-6"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_048","doi-asserted-by":"crossref","unstructured":"van Schaik, J, Begijn, DGA, van Iersel, L, Vergeer, Y, Hoving, EW, Peeters, B, et al.. Experiences with glucagon-like Peptide-1 receptor agonist in children with acquired hypothalamic obesity. Obes Facts 2020;13:361\u201370. https:\/\/doi.org\/10.1159\/000509302.","DOI":"10.1159\/000509302"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_049","doi-asserted-by":"crossref","unstructured":"Zoicas, F, Droste, M, Mayr, B, Buchfelder, M, Schofl, C. GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases. Eur 2013;168:699\u2013706. https:\/\/doi.org\/10.1530\/eje-12-0997.","DOI":"10.1530\/EJE-12-0997"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_069","unstructured":"Harat, M, Rudas, M, Sokal, P, Zielinski, P. Morbid obesity treated with bilateral nucleus accumbens stimulation-a two cases report. Stereotact Funct Neurosurg 2014;2:s108."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_068","doi-asserted-by":"crossref","unstructured":"Harat, M, Rudas, M, Zielinski, P, Birska, J, Sokal, P. Nucleus accumbens stimulation in pathological obesity. Neurol Neurochir Pol 2016;50:207\u201310. https:\/\/doi.org\/10.1016\/j.pjnns.2016.01.014.","DOI":"10.1016\/j.pjnns.2016.01.014"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_065","doi-asserted-by":"crossref","unstructured":"Inge, TH, Pfluger, P, Zeller, M, Rose, SR, Burget, L, Sundararajan, S, et al.. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nature clin 2007;3:606\u20139. https:\/\/doi.org\/10.1038\/ncpendmet0579.","DOI":"10.1038\/ncpendmet0579"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_064","unstructured":"Muller, H, Gebhardt, U, Wessel, V, Schroder, S, Kolb, R, Sorensen, N, et al.. First experiences with laparoscopic adjustable gastric banding for the treatment of morbid obesity in patients with childhood craniopharyngioma. Neuro Oncol 2008;10:402."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_067","unstructured":"Obara-Moszynska, M, Harat, M, Niedziela, M. Severe hypothalamic obesity in a girl with craniopharyngioma-case report. Hormone Res Paediatr 2015;1:427\u20138."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_066","doi-asserted-by":"crossref","unstructured":"Schultes, B, Ernst, B, Schmid, F, Thurnheer, M. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur 2009;161:201\u20136. https:\/\/doi.org\/10.1530\/eje-09-0079.","DOI":"10.1530\/EJE-09-0079"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_070","doi-asserted-by":"crossref","unstructured":"Chai-Udom, R, Aroonparkmongkol, S, Sahakitrungruang, T. Metabolic features and changes in glucose-induced serum glucagon-like peptide-1 levels in children with hypothalamic obesity. J Pediatr Endocrinol Metab 2020;33:331\u20137. https:\/\/doi.org\/10.1515\/jpem-2017-0350.","DOI":"10.1515\/jpem-2017-0350"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_071","doi-asserted-by":"crossref","unstructured":"Daousi, C, MacFarlane, IA, English, PJ, Wilding, JPH, Patterson, M, Dovey, TM, et al.. Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage? J Clin Endocrinol Metab 2005;90:5025\u201330. https:\/\/doi.org\/10.1210\/jc.2004-1874.","DOI":"10.1210\/jc.2004-1874"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_072","doi-asserted-by":"crossref","unstructured":"Martins, CS, Nogueira, MC, Bueno, AC, Berbel-Junior, AS, Moreira, AC, Antonini, SR, et al.. Appetite and food intake-regulating hormones in patients with craniopharyngioma. J Endo Soci 2023;7:A10\u20131.","DOI":"10.1210\/jendso\/bvad114.018"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_074","unstructured":"Balestrino, R, Losa, M, Barzaghi, L, Agosta, F, Filippi, M, Mortini, P, et al.. Neuro-psychological and metabolic complications of craniopharyngioma: a retrospective study. Neurol Sci 2022;43:S385\u20136."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_073","doi-asserted-by":"crossref","unstructured":"Ondruch, A, Maryniak, A, Kropiwnicki, T, Roszkowski, M, Daszkiewicz, P. Cognitive and social functioning in children and adolescents after\u00a0the\u00a0removal of craniopharyngioma. Childs Nerv Syst 2011;27:391\u20137. https:\/\/doi.org\/10.1007\/s00381-010-1301-0.","DOI":"10.1007\/s00381-010-1301-0"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_076","unstructured":"Hinton, EC, Narayan, K, Elsworth, RL, Lithander, FE, Naeem, N, Elson, R, et al.. Insulin resistance following childhood craniopharyngioma may influence neural response to food cues in food reward-related brain regions: a preliminary investigation. Hormone Research in Paediatrics Conference: 53rd Annual Meeting of the European Society for Paediatric Endocrinology, ESPE 2021;82."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_075","doi-asserted-by":"crossref","unstructured":"Lee, M, Park, MJ, Lee, KH, Kim, JH, Choi, HJ, Kim, YH, et al.. Obesity mechanism after hypothalamic damage: cohort analysis of neuroimaging, psychological, cognitive, and clinical phenotyping data. Front Endocrinol 2023;14. https:\/\/doi.org\/10.3389\/fendo.2023.1114409.","DOI":"10.3389\/fendo.2023.1114409"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_077","doi-asserted-by":"crossref","unstructured":"Nogueira, MC, Berbel Junior, AS, Koenigkam-Santos, M, Moreira, AC, Nonino, CB, de Castro, M, et al.. Nutritional and endocrinologic evaluation of patients with craniopharyngioma. Clin Nutr ESPEN 2015;10:e213\u20138. https:\/\/doi.org\/10.1016\/j.clnesp.2015.06.001.","DOI":"10.1016\/j.clnesp.2015.06.001"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_062","doi-asserted-by":"crossref","unstructured":"Kuhnen, P, Clement, K, Wiegand, S, Blankenstein, O, Gottesdiener, K, Martini, LL, et al.. Proopiomelanocortin deficiency treated with a Melanocortin-4 receptor agonist. N Engl J Med 2016;375:240\u20136. https:\/\/doi.org\/10.1056\/nejmoa1512693.","DOI":"10.1056\/NEJMoa1512693"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_078","unstructured":"Hinton, EC, Lithander, FE, Elsworth, RL, Naeem, N, Elson, R, Narayan, K, et al.. Eating behaviour following childhood craniopharyngioma. Obes Rev 2020;21:e13118."},{"key":"2026030907573193812_j_jpem-2025-0589_ref_079","doi-asserted-by":"crossref","unstructured":"Kluzek, S, Dean, B, Wartolowska, KA. Patient-reported outcome measures (PROMs) as proof of treatment efficacy. BMJ Evid Based Med 2022;27:153\u20135. https:\/\/doi.org\/10.1136\/bmjebm-2020-111573.","DOI":"10.1136\/bmjebm-2020-111573"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_080","doi-asserted-by":"crossref","unstructured":"Stunkard, AJ, Messick, S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71\u201383. https:\/\/doi.org\/10.1016\/0022-3999(85)90010-8.","DOI":"10.1016\/0022-3999(85)90010-8"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_081","doi-asserted-by":"crossref","unstructured":"Hunot-Alexander, C, Arellano-Gomez, LP, Smith, AD, Kaufer-Horwitz, M, Vasquez-Garibay, EM, Romero-Velarde, E, et al.. Examining the validity and consistency of the adult eating behaviour questionnaire-espanol (AEBQ-Esp) and its relationship to BMI in a Mexican population. Eat Weight Disord 2022;27:651\u201363. https:\/\/doi.org\/10.1007\/s40519-021-01201-9.","DOI":"10.1007\/s40519-021-01201-9"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_082","doi-asserted-by":"crossref","unstructured":"Wardle, J, Guthrie, CA, Sanderson, S, Rapoport, L. Development of the children\u2019s eating behaviour questionnaire. J Child Psychol Psychiatry 2001;42:963\u201370. https:\/\/doi.org\/10.1111\/1469-7610.00792.","DOI":"10.1111\/1469-7610.00792"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_083","doi-asserted-by":"crossref","unstructured":"Lawrence, NS, O\u2019Sullivan, J, Parslow, D, Javaid, M, Adams, RC, Chambers, CD, et al.. Training response inhibition to food is associated with weight loss and reduced energy intake. Appetite 2015;95:17\u201328. https:\/\/doi.org\/10.1016\/j.appet.2015.06.009.","DOI":"10.1016\/j.appet.2015.06.009"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_084","doi-asserted-by":"crossref","unstructured":"Chadda, KR, Cheng, TS, Ong, KK. GLP-1 agonists for obesity and type 2 diabetes in children: systematic review and meta-analysis. Obes Rev 2021;22. https:\/\/doi.org\/10.1111\/obr.13177.","DOI":"10.1111\/obr.13177"},{"key":"2026030907573193812_j_jpem-2025-0589_ref_085","doi-asserted-by":"crossref","unstructured":"Iqbal, J, Wu, HX, Hu, N, Zhou, YH, Li, L, Xiao, F, et al.. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials. Obes Rev 2022;23. https:\/\/doi.org\/10.1111\/obr.13435.","DOI":"10.1111\/obr.13435"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0589\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:58:50Z","timestamp":1773043130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0589\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2,23]]},"published-print":{"date-parts":[[2026,3,26]]}},"alternative-id":["10.1515\/jpem-2025-0589"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0589","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}